JAMA Editor’s Summary

Spotlight on the new ACC/AHA lipid and JNC8 hypertension guidelines, EGFR inhibitors vs chemotherapy for NSCLC, and more.

Editor's Audio Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor, the Journal of the American Medical Association, for the April 09, 2014 issue

April 8, 2014

Listen on your favorite player Take me to this show’s page

Newer →

Safety of balloon- vs self-expandable TAVR valves, effects of aleglitazar and metformin after ACS in patients with DM, management of fibromyalgia, and more.

← Older

JAMA: 2014-04-01, Vol. 311, No. 13, Editor's Audio Summary

Facebook Twitter Buffer LinkedIn WhatsApp

Spotlight on the new ACC/AHA lipid and JNC8 hypertension guidelines, EGFR inhibitors vs chemotherapy for NSCLC, and more.

Editor’s Audio Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor, the Journal of the American Medical Association, for the April 09, 2014 issue